Search alternatives:
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
mean decrease » a decrease (Expand Search)
cloud rate » load rate (Expand Search), cloud base (Expand Search)
a large » _ large (Expand Search)
a mean » _ mean (Expand Search)
Showing 61 - 80 results of 30,651 for search '(((( ((cloud rate) OR (cloud data)) decreased ) OR ( a mean decrease ))) OR ( a large decrease ))', query time: 1.85s Refine Results
  1. 61
    Flow cytometry data of NC28.1 cells transfected with the dual cassette plasmid and selected with 800 μg/ml hygromycin.

    Flow cytometry data of NC28.1 cells transfected with the dual cassette plasmid and selected with 800 μg/ml hygromycin. by Xinwen Zhu (14709669)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  2. 62
    Flow cytometry data of AX4 cells transfected with the dual cassette plasmid and selected with 150 μg/ml hygromycin.

    Flow cytometry data of AX4 cells transfected with the dual cassette plasmid and selected with 150 μg/ml hygromycin. by Xinwen Zhu (14709669)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  3. 63
    Flow cytometry data of NC28.1 cells transfected with the dual cassette plasmid and selected with 400 μg/ml hygromycin.

    Flow cytometry data of NC28.1 cells transfected with the dual cassette plasmid and selected with 400 μg/ml hygromycin. by Xinwen Zhu (14709669)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  4. 64
    Flow cytometry data of AX4 cells transfected with the P2A plasmid and selected with 200 μg/ml hygromycin.

    Flow cytometry data of AX4 cells transfected with the P2A plasmid and selected with 200 μg/ml hygromycin. by Xinwen Zhu (14709669)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  5. 65
    Flow cytometry data of AX4 cells transfected with the dual cassette plasmid and selected with 100 μg/ml hygromycin.

    Flow cytometry data of AX4 cells transfected with the dual cassette plasmid and selected with 100 μg/ml hygromycin. by Xinwen Zhu (14709669)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  6. 66
    Flow cytometry data of NC28.1 cells transfected with the P2A plasmid and selected with 400 μg/ml hygromycin.

    Flow cytometry data of NC28.1 cells transfected with the P2A plasmid and selected with 400 μg/ml hygromycin. by Xinwen Zhu (14709669)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  7. 67
    Flow cytometry data of NC28.1 cells transfected with the P2A plasmid and selected with 600 μg/ml hygromycin.

    Flow cytometry data of NC28.1 cells transfected with the P2A plasmid and selected with 600 μg/ml hygromycin. by Xinwen Zhu (14709669)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  8. 68
    Flow cytometry data of NC28.1 cells transfected with the P2A plasmid and selected with 800 μg/ml hygromycin.

    Flow cytometry data of NC28.1 cells transfected with the P2A plasmid and selected with 800 μg/ml hygromycin. by Xinwen Zhu (14709669)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  9. 69
    NSC population and proliferation decrease drastically during the second postnatal week of DG development.

    NSC population and proliferation decrease drastically during the second postnatal week of DG development. by Cristina Medina-Menéndez (21800157)

    Published 2025
    Save to List
    Saved in:
  10. 70
    VM reallocation mean (sec) using scenario 1.

    VM reallocation mean (sec) using scenario 1. by Madhusudhan H. S. (16819564)

    Published 2023
    “…<div><p>Virtualisation is a major technology in cloud computing for optimising the cloud data centre’s power usage. …”
    Save to List
    Saved in:
  11. 71
    VM reallocation mean (sec) using scenario 2.

    VM reallocation mean (sec) using scenario 2. by Madhusudhan H. S. (16819564)

    Published 2023
    “…<div><p>Virtualisation is a major technology in cloud computing for optimising the cloud data centre’s power usage. …”
    Save to List
    Saved in:
  12. 72
    Study Flow Diagram.

    Study Flow Diagram. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  13. 73
    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90.

    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  14. 74
    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments).

    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  15. 75
    Antibody and antigen responses to Ensovibep vs placebo day 1–90.

    Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  16. 76
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  17. 77
    Radial gas phase volume fraction cloud diagram with different mass flow rate.

    Radial gas phase volume fraction cloud diagram with different mass flow rate. by Longfei Dong (17616195)

    Published 2023
    Save to List
    Saved in:
  18. 78
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  19. 79
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  20. 80
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:

Search Tools: